Further testing with immunohistochemistry confirmed the diagnosis of sebaceous carcinoma in situ, showing a loss of staining for MSH-2 and MSH-6 (Figures 4-5). The diagnosis of sebaceous carcinoma in situ raised the suspicion for MTS, given its frequent association with the syndrome. The gene discussed is MSH2; the disease is deafness dystonia syndrome.